UBS Group’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-36,002
| Closed | -$15.5K | – | 10713 |
|
|
2024
Q3 | $15.5K | Buy |
36,002
+31,260
| +659% | +$17.3K | ﹤0.01% | 7512 |
|
|
2024
Q2 | $2.98K | Buy |
4,742
+810
| +21% | +$825 | ﹤0.01% | 8273 |
|
|
2024
Q1 | $6.96K | Buy |
3,932
+2,788
| +244% | +$3.86K | ﹤0.01% | 7422 |
|
|
2023
Q4 | $2.16K | Buy |
1,144
+1,142
| +57,100% | +$4.5K | ﹤0.01% | 8149 |
|
|
2023
Q3 | $13 | Buy |
+2
| New | +$17 | ﹤0.01% | 9185 |
|
|
2023
Q1 | – | Sell |
-80
| Closed | -$334 | – | 10684 |
|
|
2022
Q4 | $334 | Sell |
80
-1,775
| -96% | -$8.35K | ﹤0.01% | 10240 |
|
|
2022
Q3 | $10K | Buy |
+1,855
| New | +$35.4K | ﹤0.01% | 8470 |
|
|
2022
Q2 | – | Sell |
-12
| Closed | -$1K | – | 11143 |
|
|
2022
Q1 | $1K | Sell |
12
-55
| -82% | -$2.8K | ﹤0.01% | 9971 |
|
|
2021
Q4 | $5K | Buy |
67
+57
| +570% | +$4.39K | ﹤0.01% | 9428 |
|
|
2021
Q3 | $1K | Sell |
10
-194
| -95% | -$15.1K | ﹤0.01% | 9280 |
|
|
2021
Q2 | $17K | Buy |
+204
| New | +$15.5K | ﹤0.01% | 7532 |
|
|
2020
Q3 | – | Sell |
-21
| Closed | -$1K | – | 8507 |
|
|
2020
Q2 | $1K | Sell |
21
-110
| -84% | -$4.96K | ﹤0.01% | 7818 |
|
|
2020
Q1 | $6K | Buy |
131
+100
| +323% | +$4.71K | ﹤0.01% | 7245 |
|
|
2019
Q4 | $1K | Sell |
31
-38
| -55% | -$1.64K | ﹤0.01% | 7994 |
|
|
2019
Q3 | $3K | Buy |
+69
| New | +$3.04K | ﹤0.01% | 7671 |
|
|
2019
Q1 | – | Sell |
-214
| Closed | -$7K | – | 8277 |
|
|
2018
Q4 | $7K | Buy |
214
+89
| +71% | +$3.92K | ﹤0.01% | 7430 |
|
|
2018
Q3 | $7K | Buy |
+125
| New | +$7.92K | ﹤0.01% | 7350 |
|
|
2018
Q1 | – | Sell |
-29
| Closed | -$7K | – | 8240 |
|
|
2017
Q4 | $7K | Hold |
29
| – | – | ﹤0.01% | 7250 |
|
|
2017
Q3 | $6K | Hold |
29
| – | – | ﹤0.01% | 7165 |
|
|
2017
Q2 | $4K | Buy |
+29
| New | +$5.48K | ﹤0.01% | 7228 |
|
|
2016
Q4 | – | Sell |
-53
| Closed | -$10K | – | 8102 |
|
|
2016
Q3 | $10K | Buy |
+53
| New | +$7.95K | ﹤0.01% | 6797 |
|
|
2015
Q3 | – | Sell |
-18
| Closed | -$4K | – | 8691 |
|
|
2015
Q2 | $4K | Sell |
18
-25
| -58% | -$4.77K | ﹤0.01% | 8000 |
|
|
2015
Q1 | $8K | Sell |
43
-23
| -35% | -$6.78K | ﹤0.01% | 7840 |
|
|
2014
Q4 | $14K | Buy |
+66
| New | +$14.3K | ﹤0.01% | 8098 |
|
UBS Group's NTBL Position: Q4 2024 in Review
UBS Group sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q4 2024, closing a stake of 36,002 shares — an estimated $15.5K sold.
UBS Group first reported a position in NTBL in Q4 2014 and held it in 24 quarters. The position peaked at $17K in Q2 2021. 0 funds tracked by Wall St. Rank hold NTBL as of Q4 2024.
- UBS Group reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q4 2024 after selling out during the quarter.
- UBS Group sold 36,002 Notable Labs, Ltd. Ordinary Shares shares in Q4 2024, an estimated $15.5K.
- UBS Group first reported a position in Notable Labs, Ltd. Ordinary Shares in Q4 2014 and held it in 24 quarters.
- UBS Group's Notable Labs, Ltd. Ordinary Shares position peaked at $17K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q4 2024.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.